Regulating signaling pathways to restore immune homeostasis to fight cancer and autoimmune diseases
We have designed targeted, novel drugs to re-establish immune balance. Our groundbreaking strategies activate or down-modulate the immune system to fight cancer and autoimmune diseases.
We are first and foremost a target discovery platform, which has fueled our robust pipeline. Our portfolio includes first-in-class assets with the potential to target large indications with high unmet need. Our work has generated a broad pipeline of immunomodulators able to enhance or inhibit different signaling pathways.
We've assembled an experienced management team and world-renowned advisors with substantial expertise from small and large biopharma to generate an innovative pipeline for cancer and autoimmune diseases.
At Georgiamune, we've built a team of passionate and driven scientists, clinicians, and commercial experts to bring the full potential of immunotherapy to bear.